Production of human papillomavirus type 16 virus-like particles in transgenic plants

Journal of Virology

Volumn 77, Issue 17, 2003, Pages 9211-9220

  Biemelt, Sophia ^a   Sonnewald, Uwe ^a   Galmbacher, Petra ^b   Willmitzer, Lothar ^c   Müller, Martin ^b  

^a LEIBNIZ INSTITUTE OF PLANT GENETICS AND CROP PLANT RESEARCH IPK   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c MAX PLANCK INSTITUTE OF MOLECULAR PLANT PHYSIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; EPITOPE; PROTEIN L1; UNCLASSIFIED DRUG; VACCINE; VIRUS PROTEIN; WART VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACULOVIRUS; CAULIFLOWER MOSAIC VIRUS; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; POTATO; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CONFORMATION; PROTEIN EXPRESSION; TOBACCO; TRANSGENIC PLANT; UTERINE CERVIX CANCER; VACCINATION; VIRUS INFECTION; VIRUS PARTICLE; VIRUS TRANSCRIPTION; WART VIRUS;

ANIMALS; CAPSID PROTEINS; ENHANCER ELEMENTS (GENETICS); FEMALE; GENE EXPRESSION; GENES, VIRAL; HUMANS; MICE; MICE, INBRED BALB C; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PLANTS, GENETICALLY MODIFIED; SOLANUM TUBEROSUM; TOBACCO; TOBACCO MOSAIC VIRUS; TUMOR VIRUS INFECTIONS; VACCINES, EDIBLE; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 0041888350     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.17.9211-9220.2003     Document Type: Article

References (49)

1. Arakawa, T., J. Yu, D. K. Chong, J. Hough, P. C. Engen, and W. H. Langridge. 1998. A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes. Nat. Biotechnol. 16:934-938.
2. Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, K. V. Shah, et al. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87:796-802.
3. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
4. Breitburd, F., R. Kirnbauer, N. L. Hubbert, B. Nonnenmacher, C. Trin-Dinh-Desmarquet, G. Orth, J. T. Schiller, and D. R. Lowy. 1995. Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J. Virol. 69:3959-3963.
5. Chargelegue, D., P. Obregon, and P. M. Drake. 2001. Transgenic plants for vaccine production: expectations and limitations. Trends Plant Sci. 6:495-496.
6. Daniell, H., M. S. Khan, and L. Allison. 2002. Milestones in chloroplast genetic engineering: an environmentally friendly era in biotechnology. Trends Plant Sci. 7:84-91.
7. Daniell, H., S. J. Streatfield, and K. Wycoff. 2001. Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci. 6:219-226.
8. De Cosa, B., W. Moar, S. B. Lee, M. Miller, and H. Daniell. 2001. Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals. Nat. Biotechnol. 19:71-74.
9. Franconi, R., P. Di Bonito, F. Dibello, L. Accardi, A. Müller, A. Cirilli, P. Simeone, M. G. Dona, A. Venuti, and C. Giorgi. 2002. Plant-derived human papillomavirus 16 E7 oncoprotein induces immune response and specific tumor protection. Cancer Res. 62:3654-3658.
10. Gallie, D. R., D. E. Sleat, J. W. Watts, P. C. Turner, and T. M. Wilson. 1987. The 5′-leader sequence of tobacco mosaic virus RNA enhances the expression of foreign gene transcripts in vitro and in vivo. Nucleic Acids Res. 15:3257-3273.
11. Gerber, S., C. Lane, D. M. Brown, E. Lord, M. DiLorenzo, J. D. Clements, E. Rybicki, A. L. Williamson, and R. C. Rose. 2001. Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA. J. Virol. 75:4752-4760.
12. Giddings, G., G. Allison, D. Brooks, and A. Carter. 2000. Transgenic plants as factories for biopharmaceuticals. Nat. Biotechnol. 18:1151-1155.
13. Hagensee, M. E., N. Yaegashi, and D. A. Galloway. 1993. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J. Virol. 67:315-322.
14. Höfgen, R., and L. Willmitzer. 1990. Biochemical and genetic analysis of different patatin isoforms expressed in various organs of potato (Solanum tuberosum L.) plant. Science 66:221-230.
15. Howley, P., and D. Lowy. 2002. Papillomaviruses and their replication, p. 2197-2230. In D. Knipe and P. Howley (ed.), Fields virology, 4th ed., vol. 2. Lippincott Williams and Wilkins, London, United Kingdom.
16. Iyengar, S., K. V. Shah, K. L. Kotloff, S. J. Ghim, and R. P. Viscidi. 1996. Self-assembly of in vitro-translated human papillomavirus type 16 L1 capsid protein into virus-like particles and antigenic reactivity of the protein. Clin. Diagn. Lab. Immunol. 3:733-739.
17. Kennedy, I. M., J. K. Haddow, and J. B. Clements. 1991. A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability. J. Virol. 65:2093-2097.
18. Kirnbauer, R., J. Taub, H. Greenstone, R. Roden, M. Durst, L. Gissmann, D. R. Lowy, and J. T. Schiller. 1993. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J. Virol. 67:6929-6936.
19. Koutsky, L. A., K. A. Ault, C. M. Wheeler, D. R. Brown, E. Barr, F. B. Alvarez, L. M. Chiacchierini, and K. U. Jansen. 2002. A controlled trial of a human papillomavirus type 16 vaccine. N. Engl. J. Med. 347:1645-1651.
20. Lauterslager, T. G., D. E. Florack, T. J. van der Wal, J. W. Molthoff, J. P. Langeveld, D. Bosch, W. J. Boersma, and L. A. Hilgers. 2001. Oral immunisation of naive and primed animals with transgenic potato tubers expressing LT-B. Vaccine 19:2749-2755.
21. Leder, C., J. A. Kleinschmidt, C. Wiethe, and M. Müller. 2001. Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene 11 for DNA vaccination purposes. J. Virol. 75:9201-9209.
22. Lenz, P., P. M. Day, Y. Y. Pang, S. A. Frye, P. N. Jensen, D. R. Lowy, and J. T. Schiller. 2001. Papillomavirus-like particles induce acute activation of dendritic cells. J. Immunol. 166:5346-5355.
23. Logemann, J., J. Schell, and L. Willmitzer. 1987. Improved method for the isolation of RNA from plant tissues. Anal. Biochem. 163:16-20.
24. Lowy, D. R., and J. T. Schiller. 1999. Papillomaviruses: prophylactic vaccine prospects. Biochim. Biophys. Acta 1423:M1-M8.
25. Mason, H. S., J. M. Ball, J. J. Shi, X. Jiang, M. K. Estes, and C. J. Arntzen. 1996. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc. Natl. Acad. Sci. USA 93:5335-5340.
26. Müller, M., L. Gissmann, R. J. Cristiano, X. Y. Sun, I. H. Frazer, A. B. Jenson, A. Alonso, H. Zentgraf, and J. Zhou. 1995. Papillomavirus capsid binding and uptake by cells from different tissues and species. J. Virol. 69:948-954.
27. Müller, M., J. Zhou, T. D. Reed, C. Rittmüller, A. Burger, J. Gabelsberger, J. Braspenning, and L. Gissmann. 1997. Chimeric papillomavirus-like particles. Virology 234:93-111.
28. Nakamura, Y., T. Gojobori, and T. Ikemura. 2000. Codon usage tabulated from international DNA sequence databases: status for the year 2000. Nucleic Acids Res. 28:292.
29. Neeper, M. P., K. J. Hofmann, and K. U. Jansen. 1996. Expression of the major capsid protein of human papillomavirus type 11 in Saccharomyces cerevisiae. Gene 180:1-6.
30. Ogra, P. L., H. Faden, and R. C. Welliver. 2001. Vaccination strategies for mucosal immune responses. Clin. Microbiol. Rev. 14:430-445.
31. Parkin, D. M., P. Pisani, and J. Ferlay. 1999. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer 80:827-841.
32. Pisani, P., F. Bray, and D. M. Parkin. 2002. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int. J. Cancer 97:72-81.
33. Richter, L. J., Y. Thanavala, C. J. Arntzen, and H. S. Mason. 2000. Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat. Biotechnol. 18:1167-1171.
34. Rocha-Sosa, M., U. Sonnewald, W. B. Frommer, M. Stratmann, J. Schell, and L. Willmitzer. 1989. Both developmental and metabolic signals activate the promoter of a class I patatin gene. EMBO J. 8:23-29.
35. Rosahl, S., J. Schell, and L. Willmitzer. 1987. Expression of a tuber-specific storage protein in transgenic tobacco plants: demonstration of an esterase activity. EMBO J. 6:1155-1159.
36. Rose, R. C., C. Lane, S. Wilson, J. A. Suzich, E. Rybicki, and A. L. Williamson. 1999. Oral vaccination of mice with human papillomavirus virus-like particles induces systemic virus-neutralizing antibodies. Vaccine 17:2129-2135.
37. Rudolf, M. P., S. C. Fausch, D. M. Da Silva, and W. M. Kast. 2001. Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human t cell responses in vitro. J. Immunol. 166:5917-5924.
38. Sasagawa, T., P. Pushko, G. Steers, S. E. Gschmeissner, M. A. Hajibagheri, J. Finch, L. Crawford, and M. Tommasino. 1995. Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe. Virology 206:126-135.
39. Schiller, J. T. 1999. Papillomavirus-like particle vaccines for cervical cancer. Mol. Med. Today 5:209-215.
40. Schiller, J. T., and A. Hidesheim. 2000. Developing HPV virus-like particle vaccines to prevent cervical cancer: a progress report. J. Clin. Virol. 19:67-74.
41. Schwartz, S. 2000. Regulation of human papillomavirus late gene expression Ups. J. Med. Sci. 105:171-192.
42. Sonnewald, U. 1992. Expression of E. coli inorganic pyrophosphatase in transgenic plants alters photoassimilate partitioning. Plant J. 2:571-581.
43. Suzich, J. A., S. J. Ghim, F. J. Palmer-Hill, W. I. White, J. K. Tamura, J. A. Bell, J. A. Newsome, A. B. Jenson, and R. Schlegel. 1995. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc. Natl. Acad. Sci. USA 92:11553-11557.
44. Tacket, C. O., H. S. Mason, G. Losonsky, M. K. Estes, M. M. Levine, and C. J. Arntzen. 2000. Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. J Infect. Dis. 182:302-305.
45. Wistuba, A., S. Weger, A. Kern, and J. A. Kleinschmidt. 1995. Intermediates of adeno-associated virus type 2 assembly: identification of soluble complexes containing Rep and Cap proteins. J. Virol. 69:5311-5319.
46. Yuan, H., P. A. Estes, Y. Chen, J. Newsome, V. A. Olcese, R. L. Garcea, and R. Schlegel. 2001. Immunization with a pentameric L1 fusion protein protects against papillomavirus infection. J. Virol. 75:7848-7853.
47. Zhou, J., W. J. Liu, S. W. Peng, X. Y. Sun, and I. Frazer. 1999. Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability. J. Virol. 73:4972-4982.
48. Zhou, J., X. Y. Sun, D. J. Stenzel, and I. H. Frazer. 1991. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology 185:251-257.
49. zur Hausen, H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2:342-350.